These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23160400)

  • 21. Inflammation and atherosclerosis--revisited.
    Pant S; Deshmukh A; Gurumurthy GS; Pothineni NV; Watts TE; Romeo F; Mehta JL
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):170-8. PubMed ID: 24177335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Pro-resolution" and anti-inflammation, a role of RvE1 in anti-atherosclerosis and plaque stabilization.
    Wu C; Sun A; Zou Y; Ge J
    Med Hypotheses; 2008 Aug; 71(2):252-5. PubMed ID: 18495368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-cytokine therapy for prevention of atherosclerosis.
    Kirichenko TV; Sobenin IA; Nikolic D; Rizzo M; Orekhov AN
    Phytomedicine; 2016 Oct; 23(11):1198-210. PubMed ID: 26781385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapies targeting innate immunity for fighting inflammation in atherosclerosis.
    Mendel I; Yacov N; Harats D; Breitbart E
    Curr Pharm Des; 2015; 21(9):1185-95. PubMed ID: 25312734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proximal signaling molecules as potential targets for anti-inflammatory therapy.
    Löwenberg M
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):560-4. PubMed ID: 17786854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phospholipase A2 inhibitors.
    Garcia-Garcia HM; Serruys PW
    Curr Opin Lipidol; 2009 Aug; 20(4):327-32. PubMed ID: 19550325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral serine protease inhibitors as anti-atherosclerotic therapy.
    Bot I; van Berkel TJ; Biessen EA
    Curr Opin Investig Drugs; 2007 Sep; 8(9):729-35. PubMed ID: 17729184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plaque biology: interesting science or pharmacological treasure trove?
    Loftus I; Thompson M
    Eur J Vasc Endovasc Surg; 2008 Nov; 36(5):507-16. PubMed ID: 18625571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view.
    Ridker PM
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S9-12. PubMed ID: 10070810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory strategies in coronary atherosclerosis.
    Burton PB; Daniel TO
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1725-8. PubMed ID: 12528306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
    Corti R
    Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease.
    Yamashita T; Sasaki N; Kasahara K; Hirata K
    J Cardiol; 2015 Jul; 66(1):1-8. PubMed ID: 25744783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging anti-inflammatory therapies for atherosclerosis.
    Roubille F; Kritikou EA; Roubille C; Tardif JC
    Curr Pharm Des; 2013; 19(33):5840-9. PubMed ID: 23438958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
    Momi S; Monopoli A; Alberti PF; Falcinelli E; Corazzi T; Conti V; Miglietta D; Ongini E; Minuz P; Gresele P
    Cardiovasc Res; 2012 Jun; 94(3):428-38. PubMed ID: 22362817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010--present).
    Magrioti V; Kokotos G
    Expert Opin Ther Pat; 2013 Mar; 23(3):333-44. PubMed ID: 23294257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Haque S; Mirjafari H; Bruce IN
    Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.